Workflow
动量投资
icon
搜索文档
Halozyme Therapeutics (HALO) Is Up 2.63% in One Week: What You Should Know
ZACKS· 2025-09-19 17:02
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...
Calix (CALX) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-09-18 17:01
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...
DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-09-17 17:01
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...
Century Aluminum (CENX) Is Up 18.11% in One Week: What You Should Know
ZACKS· 2025-09-16 17:02
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...
Dorman Products (DORM) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-09-12 17:00
核心观点 - 动量投资策略聚焦于追踪股票近期价格趋势 旨在通过跟随已形成的价格方向实现盈利 [1] - 多曼产品公司凭借强劲的动量表现和盈利预期上调 成为当前值得关注的动量投资标的 [3][12] 价格表现 - 公司股价过去一周上涨1.16% 同期汽车替换零件行业下跌1.14% [6] - 月度涨幅达5.02% 优于行业4.05%的表现 [6] - 季度涨幅34.36% 年度涨幅46.38% 显著超越标普500指数同期9.68%和20%的涨幅 [7] - 近期20日平均交易量为178,574股 量价配合表现良好 [8] 盈利预期 - 过去两个月内 全年盈利预期获2次上调 无下调 [10] - 共识预期从7.85美元提升至8.75美元 增幅达11.5% [10] - 下一财年同样获2次预期上调 无负面修正 [10] 评级表现 - 公司获得Zacks动量风格评分A级 同时位列Zacks排名第2级(买入) [3][4] - 研究显示同时具备Zacks买入评级和A/B级风格评分的股票在未来一个月内通常跑赢市场 [4]
Galectin Therapeutics Inc. (GALT) Is Up 7.48% in One Week: What You Should Know
ZACKS· 2025-09-12 17:00
动量投资方法论 - 动量投资策略依赖追踪股票近期价格趋势 通过买入上涨股票并期待更高价卖出实现盈利[1] - 该策略核心在于利用已确立的价格趋势 认为股票更可能延续当前方向运动[1] - Zacks动量风格评分系统帮助量化难以定义的动量指标[2] Galectin Therapeutics动量表现 - 公司获得B级动量风格评分 且拥有Zacks2(买入)评级[3][4] - 过去一周股价上涨7.48% 同期医药-药品行业持平[6] - 月度涨幅达57.98% 显著超越行业1.35%的表现[6] - 季度涨幅80.55% 年度涨幅119.19% 分别超越标普500的9.68%和20%[7] 交易量分析 - 20日平均交易量为251,038股 量价配合良好[8] - 上涨行情配合高于平均的成交量通常被视为看涨信号[8] 盈利预期修正 - 过去两个月内1项全年盈利预期上调 无下调[10] - 共识预期从-0.67美元改善至-0.49美元[10] - 下财年同样出现1项预期上调 无下调修正[10] 投资评级结论 - 结合动量评分B和买入评级 公司被列为近期具备上涨潜力的重点标的[12] - Zacks研究显示同时具备1/2评级和A/B级风格评分的股票在未来一个月表现通常跑赢市场[4]
Despite Fast-paced Momentum, Clear Channel Outdoor (CCO) Is Still a Bargain Stock
ZACKS· 2025-09-11 13:51
动量投资策略 - 动量投资策略主张"买高卖更高" 与传统的"低买高卖"理念相反 通过追逐趋势性股票在较短时间内获取更高收益 [1] - 该策略风险在于估值超过增长潜力时可能失去动量 导致持股成本高且上行空间有限 [1] - 更安全的做法是投资近期出现价格动量且估值合理的股票 结合动量评分与估值指标筛选 [2] Clear Channel Outdoor个股表现 - 过去四周股价上涨8.6% 反映市场关注度提升 [3] - 过去十二周累计涨幅达15.5% 显示持续动量特征 [4] - 贝塔系数为2.61 表明股价波动幅度是市场的2.61倍 具备快速动量属性 [4] 评级与估值分析 - 动量评分达到B级 显示当前为较佳入场时机 [5] - 获Zacks排名第2级(买入) 因盈利预期上调推动投资者兴趣提升 [6] - 市销率仅0.37倍 相当于每美元销售额仅需支付37美分 估值处于吸引水平 [6] 筛选方法论 - "低价快速动量"筛选系统可识别兼具价格动量与合理估值的股票 [2][7] - Zacks提供超过45种专业筛选策略 可根据投资风格选择适用方案 [8] - 研究向导工具支持策略回溯测试 验证历史盈利能力 [9]
What Makes TEGNA Inc. (TGNA) a Strong Momentum Stock: Buy Now?
ZACKS· 2025-09-03 17:01
核心观点 - 动量投资策略关注股票价格趋势的延续性 通过短期价格表现和盈利预测修正等指标识别投资机会 TEGNA公司凭借强劲的价格表现和积极的盈利预测修正 成为具有吸引力的动量投资标的 [1][2][9] 价格表现 - TEGNA股价过去一周上涨0.57% 超越广播电台电视行业0.52%的涨幅 [6] - 月度价格涨幅达29.4% 显著高于行业4.34%的平均表现 [6] - 过去季度股价上涨25.27% 过去一年累计涨幅51.11% 大幅超越标普500指数同期8.34%和14.94%的涨幅 [7] 交易量分析 - 20日平均交易量为5,474,775股 为价格走势提供支撑 [8] 盈利预测修正 - 过去两个月内 全年盈利预测出现1次上调且无下调 共识预期从1.61美元提升至1.66美元 [10] - 下一财年同样出现1次上调且无下调修正 显示分析师信心持续增强 [10] 评级表现 - TEGNA获得Zacks排名第2位(买入)评级 动量风格评分B级 [3][4][12] - 研究显示同时具备Zacks排名第1或第2和A/B级风格评分的股票在未来一个月内表现优于市场 [4]
Here's Why Enerflex (EFXT) is a Great Momentum Stock to Buy
ZACKS· 2025-09-03 17:01
动量投资方法论 - 动量投资遵循股票近期趋势 投资者在上涨趋势中买入并期待以更高价格卖出 关键在于利用价格趋势的持续性[1] - 动量指标定义存在争议 Zacks动量风格评分系统用于解决动量投资中的指标选择难题[2] Enerflex动量表现 - 公司当前动量风格评分为B级 同时获得Zacks买入评级(第2级) 研究表明买入评级且动量评分A/B级股票在未来一个月表现优于市场[3][4] - 过去一周股价上涨2.23% 同期加拿大油气勘探生产行业仅上涨1.3% 月度涨幅达25.64% 显著超越行业1.27%的表现[6] - 季度涨幅32.64% 年度涨幅81.24% 大幅超越标普500指数同期8.34%和14.94%的涨幅[7] 交易量分析 - 20日平均交易量达622,689股 量价配合良好 上涨趋势中伴随高于平均的成交量通常为看涨信号[8] 盈利预测修正 - 过去两个月内 全年盈利预测获2次上调 vs 1次下调 共识预期从0.71美元提升至0.98美元[10] - 下财年盈利预测获3次上调 且无下调修正 显示分析师持续看好公司盈利前景[10] 投资结论 - 综合动量评分B级与买入评级 公司被列为近期具备上涨潜力的重点标的[12]
InfuSystems Holdings, Inc. (INFU) Is Up 12.64% in One Week: What You Should Know
ZACKS· 2025-09-02 17:01
动量投资方法论 - 动量投资核心是追踪股票近期趋势 在上涨趋势中买入高价并期待以更高价卖出[1] - 趋势确立后更可能延续 目标是通过趋势路径实现及时盈利交易[1] - 动量指标选择存在争议 Zacks动量风格评分系统帮助界定动量特征[2] InfuSystems动量表现 - 当前动量风格评分获B级 同时拥有Zacks排名第1级(强力买入)[3][4] - 过去一周股价上涨12.64% 同期医疗产品行业持平[6] - 月度涨幅达84.27% 显著超越行业6.09%的表现[6] - 季度涨幅81.18% 年度涨幅62.1% 分别超越标普500的9.8%和15.8%[7] 交易量分析 - 20日平均交易量为354,055股 量价关系成为重要观察指标[8] - 放量上涨通常为看涨信号 放量下跌则通常为看跌信号[8] 盈利预测修正 - 过去两个月全年盈利预测获1次上调 无下调[10] - 共识预期从0.06美元大幅提升至0.26美元 增幅超过333%[10] - 下财年预测同样获1次上调 期间无任何下调修正[10] 综合评估 - 结合价格动能与盈利预测上调 INFU同时具备强力买入评级和B级动量评分[12] - 评分组合历史显示 评级1-2级且风格评分A/B级的股票在未来一月普遍跑赢市场[4]